Unexpected Resolution of Stage IV Diffuse Large B-Cell Lymphoma in an HIV-Positive Patient: A Case Study and Review of Existing Literature - Scorecard - MDSpire
Advertisement
Unexpected Resolution of Stage IV Diffuse Large B-Cell Lymphoma in an HIV-Positive Patient: A Case Study and Review of Existing Literature
Clinical Scorecard: Unexpected Resolution of Stage IV Diffuse Large B-Cell Lymphoma in an HIV-Positive Patient: A Case Study and Review of Existing Literature
At a Glance
Category
Detail
Condition
Stage IV Diffuse Large B-Cell Lymphoma (DLBCL) in HIV-positive patients
Key Mechanisms
HIV-mediated immune dysfunction leading to increased risk of lymphoma; immune reconstitution via cART may influence tumor regression.
Target Population
HIV-positive individuals with stage IV DLBCL
Care Setting
Oncology and Infectious Disease clinics
Key Highlights
Spontaneous regression of stage IV DLBCL is rare in HIV-positive patients.
The patient achieved complete radiographic resolution after initiating cART.
CD4+ T-cell recovery correlated with tumor regression.
cART should be initiated early in HIV-positive lymphoma patients.
Guideline-Based Recommendations
Diagnosis
Diagnosis of DLBCL in HIV patients should include histopathological examination and imaging studies.
Management
Standard treatment involves chemotherapy and immunotherapy, alongside cART.
Monitoring & Follow-up
Monitor CD4+ T-cell counts and HIV viral load regularly.
Risks
Patients with stage IV DLBCL have worse outcomes despite treatment.
Patient & Prescribing Data
HIV-positive individuals diagnosed with stage IV DLBCL.
cART can lead to significant immune recovery and potential tumor regression.
Clinical Best Practices
Initiate cART as early as possible in HIV-positive lymphoma patients.
Conduct regular follow-ups to monitor immune function and disease status.
